Open Access
CC BY-NC-ND 4.0 · Planta Med 2022; 88(09/10): 735-744
DOI: 10.1055/a-1843-9855
Biological and Pharmacological Activity
Original Papers

(−)-Epicatechin Reverses Glucose Intolerance in Rats Housed at Thermoneutrality[ # ]

Authors

  • Ji Hye Chun

    1   Aquillius Corp., San Diego, CA, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Melissa M. Henckel

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Leslie A. Knaub

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Sara E. Hull

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Greg B. Pott

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • David G. Ramirez

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Jane E.-B. Reusch

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA
  • Amy C. Keller

    2   Division of Endocrinology, Metabolism & Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    3   Rocky Mountain Regional VA Medical Center, Aurora, CO, USA

Gefördert durch: U.S. Department of Veteran's Affairs BX003185 Gefördert durch: NIH/NCRR CCTSI UL1 RR025780 Gefördert durch: Ludeman Family Center for Women’s Health Research at University of Colorado Anschutz Junior Faculty Research Development Grant Gefördert durch: Denver Research Institute Gefördert durch: Center for Integrated Healthcare, U.S. Department of Veterans Affairs BX002046 Gefördert durch: NIH/NIDDK R01 DK124344-01A1
Preview

Abstract

Diabetes is a life-threatening and debilitating disease with pathological hallmarks, including glucose intolerance and insulin resistance. Plant compounds are a source of novel and effective therapeutics, and the flavonoid (−)-epicatechin, common to popular foods worldwide, has been shown to improve carbohydrate metabolism in both clinical studies and preclinical models. We hypothesized that (−)-epicatechin would alleviate thermoneutral housing-induced glucose intolerance. Male rats were housed at either thermoneutral (30 °C) or room temperature (24 °C) for 16 weeks and gavaged with either 1 mg/kg body weight or vehicle for the last 15 days before sacrifice. Rats housed at thermoneutrality had a significantly elevated serum glucose area under the curve (p < 0.05) and reduced glucose-mediated insulin secretion. In contrast, rats at thermoneutrality treated with (−)-epicatechin had improved glucose tolerance and increased insulin secretion (p < 0.05). Insulin tolerance tests revealed no differences in insulin sensitivity in any of the four groups. Pancreatic immunohistochemistry staining showed significantly greater islet insulin positive cells in animals housed at thermoneutrality. In conclusion, (−)-epicatechin improved carbohydrate tolerance via increased insulin secretion in response to glucose challenge without a change in insulin sensitivity.

# Dedicated to Professor Dr. A. Douglas Kinghorn on the occasion of his 75th birthday.




Publikationsverlauf

Eingereicht: 15. November 2021

Angenommen nach Revision: 04. April 2022

Artikel online veröffentlicht:
01. Juli 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany